EP4084783A4 - Pharmaceutical solution that facilitates dental remineralisation and eliminates lesion pain - Google Patents

Pharmaceutical solution that facilitates dental remineralisation and eliminates lesion pain Download PDF

Info

Publication number
EP4084783A4
EP4084783A4 EP20911053.5A EP20911053A EP4084783A4 EP 4084783 A4 EP4084783 A4 EP 4084783A4 EP 20911053 A EP20911053 A EP 20911053A EP 4084783 A4 EP4084783 A4 EP 4084783A4
Authority
EP
European Patent Office
Prior art keywords
eliminates
pharmaceutical solution
remineralisation
lesion pain
facilitates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20911053.5A
Other languages
German (de)
French (fr)
Other versions
EP4084783A1 (en
Inventor
Fatih CETINKAYA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akdeniz Universitesi
Original Assignee
Akdeniz Universitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akdeniz Universitesi filed Critical Akdeniz Universitesi
Publication of EP4084783A1 publication Critical patent/EP4084783A1/en
Publication of EP4084783A4 publication Critical patent/EP4084783A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
EP20911053.5A 2019-12-30 2020-12-18 Pharmaceutical solution that facilitates dental remineralisation and eliminates lesion pain Withdrawn EP4084783A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201922315 2019-12-30
PCT/TR2020/051323 WO2021137809A1 (en) 2019-12-30 2020-12-18 Pharmaceutical solution that facilitates dental remineralisation and eliminates lesion pain

Publications (2)

Publication Number Publication Date
EP4084783A1 EP4084783A1 (en) 2022-11-09
EP4084783A4 true EP4084783A4 (en) 2023-04-19

Family

ID=76687379

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20911053.5A Withdrawn EP4084783A4 (en) 2019-12-30 2020-12-18 Pharmaceutical solution that facilitates dental remineralisation and eliminates lesion pain

Country Status (2)

Country Link
EP (1) EP4084783A4 (en)
WO (1) WO2021137809A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280694A1 (en) * 2005-06-09 2006-12-14 John Peldyak Composition for the mineralization of dental hard tissues and the reduction of caries-inducive microflora
WO2012119155A1 (en) * 2011-03-03 2012-09-07 American Dental Association Foundation Antimicrobial compositions for tooth fluoridation and remineralization

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9289362B2 (en) * 2005-02-15 2016-03-22 Martin S. Giniger Foaming compositions and methods
US8828363B2 (en) * 2007-08-03 2014-09-09 Gary H. EIREW Pharmaceutical composition for improving oral hygiene and methods thereof
US20190030107A1 (en) * 2017-07-31 2019-01-31 Ragan L. Faler Compositions for periodontal adjuntive therapy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280694A1 (en) * 2005-06-09 2006-12-14 John Peldyak Composition for the mineralization of dental hard tissues and the reduction of caries-inducive microflora
WO2012119155A1 (en) * 2011-03-03 2012-09-07 American Dental Association Foundation Antimicrobial compositions for tooth fluoridation and remineralization

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MALGORZATA PLESZCZYNSKA ET AL: "Enzymes in therapy of biofilm-related oral diseases", BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, ACADEMIC PRESS, US, vol. 64, no. 3, 21 September 2016 (2016-09-21), pages 337 - 346, XP071713656, ISSN: 0885-4513, DOI: 10.1002/BAB.1490 *
See also references of WO2021137809A1 *
THAI QUOC DANG ET AL: "Phytochemical study and biological evaluation of chemical constituents ofPlatanus orientalisandPlatanus x acerifoliabuds", PHYTOCHEMISTRY, ELSEVIER, AMSTERDAM , NL, vol. 130, 11 May 2016 (2016-05-11), pages 170 - 181, XP029697752, ISSN: 0031-9422, DOI: 10.1016/J.PHYTOCHEM.2016.04.006 *

Also Published As

Publication number Publication date
WO2021137809A1 (en) 2021-07-08
EP4084783A1 (en) 2022-11-09

Similar Documents

Publication Publication Date Title
EP3854816A4 (en) Anti-b7h3 antibody-exatecan analog conjugate and medicinal use thereof
AU2018231044A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
IL270812B1 (en) Solid compositions for oral administration comprising semaglutide and dapagliflozin and their use in medicine
EP3744335A4 (en) Medicinal preparation and medical instrument
EP3753557A4 (en) Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases
EP3828183A4 (en) Sulfoximine compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof
GB202001832D0 (en) Oral care dentifrice formulations and methods for use
EP4149470A4 (en) Pharmaceutical formulations and uses thereof
EP3851121A4 (en) Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition
EP3570835A4 (en) Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders
PT3817689T (en) Abutment and healing cuff device for dental implant
IL285866A (en) Pharmaceutical composition containing acetominophen and ibuprofen
EP4031520A4 (en) Imaging and therapeutic compositions
EP3777849A4 (en) Pharmaceutical composition, comprising polmacoxib and pregabalin, for treatment of pain
EP3818981A4 (en) Synergic pharmaceutical composition of the active enantiomer (s)-ketorolac and gabapentin for the treatment of neuropathic pain
EP3881843A4 (en) Prophylactic or therapeutic agent and medicinal composition for il-31-mediated disease
EP4084783A4 (en) Pharmaceutical solution that facilitates dental remineralisation and eliminates lesion pain
EP3468540A4 (en) Pharmaceutical compositions and methods for treatment of pain
EP4041263A4 (en) Oral care composition comprising cuttlefish bone powder
IL281513A (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
EP3843700A4 (en) Compositions and methods for dental care
EP3582787A4 (en) Pharmaceutical preparation for the prevention and treatment of inflammatory and degenerative diseases
PL4051249T4 (en) Pharmaceutical composition comprising mitotane for oral administration for use in the treatment of adrenocortical carcinoma and cushing-syndrome
GB202212240D0 (en) New formulations and medical uses thereof
GB202209022D0 (en) Pharmaceutical compositions and formulations for the treatment of retinoblastoma

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220704

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031000000

Ipc: A61Q0011000000

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230317

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/185 20060101ALI20230313BHEP

Ipc: A61K 33/42 20060101ALI20230313BHEP

Ipc: A61K 33/16 20060101ALI20230313BHEP

Ipc: A61K 33/00 20060101ALI20230313BHEP

Ipc: A61K 31/23 20060101ALI20230313BHEP

Ipc: A61K 31/085 20060101ALI20230313BHEP

Ipc: A61K 8/9789 20170101ALI20230313BHEP

Ipc: A61K 8/34 20060101ALI20230313BHEP

Ipc: A61K 8/21 20060101ALI20230313BHEP

Ipc: A61K 8/66 20060101ALI20230313BHEP

Ipc: A61K 8/37 20060101ALI20230313BHEP

Ipc: A61K 8/24 20060101ALI20230313BHEP

Ipc: A61K 8/19 20060101ALI20230313BHEP

Ipc: A61Q 11/00 20060101AFI20230313BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20231017